|
WDR45L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.00410000314355E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.08199999959702E-07 |
| Normal-vs-Stage2 |
1.606430E-02 |
| Normal-vs-Stage3 |
7.89529996936267E-09 |
| Normal-vs-Stage4 |
1.17220000039886E-07 |
| Stage1-vs-Stage2 |
6.796200E-02 |
| Stage1-vs-Stage3 |
1.279620E-01 |
| Stage1-vs-Stage4 |
2.356000E-01 |
| Stage2-vs-Stage3 |
8.775800E-03 |
| Stage2-vs-Stage4 |
2.341600E-02 |
| Stage3-vs-Stage4 |
8.592400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.61240000240426E-08 |
| Normal-vs-AfricanAmerican |
5.54959999999882E-05 |
| Normal-vs-Asian |
9.76050000000006E-05 |
| Caucasian-vs-AfricanAmerican |
4.925400E-01 |
| Caucasian-vs-Asian |
5.731400E-01 |
| AfricanAmerican-vs-Asian |
2.959400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.31429999953248E-07 |
| Normal-vs-Female |
1.83430000078033E-08 |
| Male-vs-Female |
7.779000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.07019999978841E-07 |
| Normal-vs-Age(41-60Yrs) |
3.74009999970504E-07 |
| Normal-vs-Age(61-80Yrs) |
4.44000000099365E-08 |
| Normal-vs-Age(81-100Yrs) |
6.595900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.195200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.993400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.657200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.636200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.560800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.672800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.599500E-02 |
| Classical-VS-Follicular |
6.546200E-01 |
| Classical-VS-Other |
2.960600E-01 |
| Classical-VS-Normal |
3.45799999745822E-08 |
| Tall-VS-Follicular |
6.738200E-02 |
| Tall-VS-Other |
8.301800E-01 |
| Tall-VS-Normal |
8.40360000031737E-07 |
| Follicular-VS-Other |
3.684600E-01 |
| Follicular-VS-Normal |
6.995100E-04 |
| Other-VS-Normal |
3.615200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.21109999995372E-06 |
| Normal-vs-N1 |
6.16639999950763E-07 |
| N0-vs-N1 |
2.409800E-01 |
|
|
